Cherie Ng

2.2k total citations · 1 hit paper
31 papers, 1.6k citations indexed

About

Cherie Ng is a scholar working on Immunology, Infectious Diseases and Virology. According to data from OpenAlex, Cherie Ng has authored 31 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Immunology, 7 papers in Infectious Diseases and 4 papers in Virology. Recurrent topics in Cherie Ng's work include Immune Cell Function and Interaction (11 papers), T-cell and B-cell Immunology (11 papers) and interferon and immune responses (4 papers). Cherie Ng is often cited by papers focused on Immune Cell Function and Interaction (11 papers), T-cell and B-cell Immunology (11 papers) and interferon and immune responses (4 papers). Cherie Ng collaborates with scholars based in United States, Italy and Canada. Cherie Ng's co-authors include Michael B. A. Oldstone, Brian M. Sullivan, John R. Teijaro, Megan J. Welch, Robert D. Schreiber, Andrew M. Lee, Kathleen C. F. Sheehan, Juan Carlos de la Torre, Juan L. Mendoza and K. Christopher García and has published in prestigious journals such as Science, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Cherie Ng

31 papers receiving 1.5k citations

Hit Papers

Persistent LCMV Infection Is Controlled by Blockade of Ty... 2013 2026 2017 2021 2013 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Cherie Ng United States 14 896 369 320 307 277 31 1.6k
Jean-Philippe Goulet Canada 18 681 0.8× 193 0.5× 392 1.2× 228 0.7× 375 1.4× 27 1.4k
Laura Fantuzzi Italy 22 847 0.9× 235 0.6× 227 0.7× 298 1.0× 563 2.0× 39 1.5k
Jean‐Philippe Herbeuval France 23 1.5k 1.7× 307 0.8× 390 1.2× 382 1.2× 835 3.0× 55 2.3k
Marina Viora Italy 25 767 0.9× 228 0.6× 325 1.0× 389 1.3× 383 1.4× 55 1.7k
Hiroshi Terunuma Japan 18 581 0.6× 377 1.0× 174 0.5× 338 1.1× 224 0.8× 58 1.4k
Margarita Bofill Spain 21 1.2k 1.3× 510 1.4× 407 1.3× 594 1.9× 881 3.2× 46 2.2k
Paola Borghi Italy 21 1.3k 1.5× 222 0.6× 341 1.1× 238 0.8× 228 0.8× 39 1.9k
J. Navarro Spain 21 739 0.8× 258 0.7× 158 0.5× 317 1.0× 295 1.1× 57 1.3k
Paula A. Velilla Colombia 20 995 1.1× 342 0.9× 157 0.5× 319 1.0× 436 1.6× 53 1.7k
Monica Vaccari United States 23 1.4k 1.6× 358 1.0× 217 0.7× 360 1.2× 1.1k 3.9× 42 2.0k

Countries citing papers authored by Cherie Ng

Since Specialization
Citations

This map shows the geographic impact of Cherie Ng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cherie Ng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cherie Ng more than expected).

Fields of papers citing papers by Cherie Ng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cherie Ng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cherie Ng. The network helps show where Cherie Ng may publish in the future.

Co-authorship network of co-authors of Cherie Ng

This figure shows the co-authorship network connecting the top 25 collaborators of Cherie Ng. A scholar is included among the top collaborators of Cherie Ng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cherie Ng. Cherie Ng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Giovannone, Adrian J., et al.. (2023). γc receptor antagonist, EQ102, prevents the NK and T cell-mediated responses driven by IL-15 and IL-21. The Journal of Immunology. 210(Supplement_1). 243.19–243.19. 2 indexed citations
2.
Koreth, John, Alison W. Loren, Ryotaro Nakamura, et al.. (2023). Final Safety and Efficacy Results from Equate, an Open-Label Study Evaluating Itolizumab, a Novel Targeted Anti-CD6 Therapy, in Newly Diagnosed Acute Graft-Versus-Host Disease. Transplantation and Cellular Therapy. 29(2). S30–S31. 2 indexed citations
4.
Putterman, Chaim, Richard Furie, Jai Radhakrishnan, et al.. (2021). Itolizumab, a Novel Anti-CD6 Therapy, in Systemic Lupus Erythematosus Patients: Interim Safety Results from the Phase 1b EQUALISE Dose-Escalation Study. Journal of the American Society of Nephrology. 32(10S). 506–506. 1 indexed citations
5.
Ampudia, Jeanette, et al.. (2020). CD6-ALCAM signaling regulates multiple effector/memory T cell functions. The Journal of Immunology. 204(1_Supplement). 150.13–150.13. 6 indexed citations
6.
Koziol‐White, Cynthia, Gaoyuan Cao, Vishal Parikh, et al.. (2020). CD6 is highly expressed in fatal asthma patients and may modulate bronchomotor tone. 320–320. 1 indexed citations
7.
Mukherjee, Manali, Katherine Radford, Sole Gatto, et al.. (2020). CD6-ALCAM Pathway is Elevated in Patients with Severe Asthma. 5283–5283. 1 indexed citations
8.
Ng, Cherie, Jeanette Ampudia, Robert J. Soiffer, Jerome Ritz, & Stephen Connelly. (2019). Itolizumab As a Potential Therapeutic for the Prevention and Treatment of Graft Vs Host Disease. Blood. 134(Supplement_1). 5603–5603. 4 indexed citations
9.
Ng, Cherie, Juan L. Mendoza, K. Christopher García, & Michael B. A. Oldstone. (2016). Alpha and Beta Type 1 Interferon Signaling: Passage for Diverse Biologic Outcomes. Cell. 164(3). 349–352. 106 indexed citations
10.
Yu, Michael, Michael H. Kramer, Janusz Dutkowski, et al.. (2016). Translation of Genotype to Phenotype by a Hierarchy of Cell Subsystems. Cell Systems. 2(2). 77–88. 52 indexed citations
11.
Gross, Andrew M., Philipp A. Jaeger, Jason F. Kreisberg, et al.. (2016). Methylome-wide Analysis of Chronic HIV Infection Reveals Five-Year Increase in Biological Age and Epigenetic Targeting of HLA. Molecular Cell. 62(2). 157–168. 210 indexed citations
12.
Ng, Cherie, Brian M. Sullivan, John R. Teijaro, et al.. (2015). Blockade of Interferon Beta, but Not Interferon Alpha, Signaling Controls Persistent Viral Infection. Cell Host & Microbe. 17(5). 653–661. 126 indexed citations
13.
Ng, Cherie & Michael B. A. Oldstone. (2014). IL-10: Achieving Balance During Persistent Viral Infection. Current topics in microbiology and immunology. 380. 129–144. 37 indexed citations
14.
Teijaro, John R., Cherie Ng, Andrew M. Lee, et al.. (2013). Persistent LCMV Infection Is Controlled by Blockade of Type I Interferon Signaling. Science. 340(6129). 207–211. 583 indexed citations breakdown →
15.
Ng, Cherie, Laura M. Snell, David G. Brooks, & Michael B. A. Oldstone. (2013). Networking at the Level of Host Immunity: Immune Cell Interactions during Persistent Viral Infections. Cell Host & Microbe. 13(6). 652–664. 62 indexed citations
16.
Ng, Cherie, Bishnu P. Nayak, Christian Schmedt, & Michael B. A. Oldstone. (2012). Immortalized clones of fibroblastic reticular cells activate virus-specific T cells during virus infection. Proceedings of the National Academy of Sciences. 109(20). 7823–7828. 27 indexed citations
17.
Ng, Cherie, Brian M. Sullivan, & Michael B. A. Oldstone. (2011). The role of dendritic cells in viral persistence. Current Opinion in Virology. 1(3). 160–166. 21 indexed citations
18.
Ng, Cherie, Juan Pablo Jaworski, Pushpa Jayaraman, et al.. (2010). Passive neutralizing antibody controls SHIV viremia and enhances B cell responses in infant macaques. Nature Medicine. 16(10). 1117–1119. 111 indexed citations
19.
Ng, Cherie, et al.. (2005). Evaluation of Policies Regarding Physicians Infected With Blood-Borne Pathogens. Infection Control and Hospital Epidemiology. 26(4). 410–414. 1 indexed citations
20.
Enanoria, Wayne, et al.. (2004). Treatment outcomes after highly active antiretroviral therapy: a meta-analysis of randomised controlled trials. The Lancet Infectious Diseases. 4(7). 414–425. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026